#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11996	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2260	526.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1479	1479	C	691	C,T	662,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11996	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2260	526.1	0	HET	.	.	.	C451T,A	.	451	451	C	746	746	C	674	C,T,A	465,183,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11996	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2260	526.1	0	HET	.	.	.	C207T	.	207	207	C	502	502	C	663	C,T	525,113	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22614	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3679	609.9	0	.	n	.	0	T695C	SNP	695	695	T	1053	1053	C	711	C	683	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22614	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3679	609.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2329	2329	C	709	C,T,G	677,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22614	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3679	609.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2403	2403	A	691	A	673	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22614	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3679	609.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2955	2955	C	661	C	647	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1352	folP	855	855	100.0	folP.l6.c30.ctg.1	1604	83.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1085	1087	AGC	138;137;137	A;G;C	135;134;134	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3594	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3470	102.9	1	SNP	p	S91F	1	.	.	271	273	TTC	596	598	TTC	124;123;121	T;T;C	122;121;117	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3594	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3470	102.9	1	SNP	p	D95G	1	.	.	283	285	GGC	608	610	GGC	120;117;118	G;G;C	117;116;115	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3594	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3470	102.9	1	SNP	p	G95N	0	.	.	283	285	GGC	608	610	GGC	120;117;118	G;G;C	117;116;115	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1226	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1307	92.5	1	SNP	p	G45D	0	.	.	133	135	GGC	472	474	GGC	131;130;131	G;G;C	125;125;127	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	544	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1104	48.9	0	.	n	.	0	A197.	DEL	197	197	A	673	673	A	121	A	115	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4208	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2879	144.6	1	SNP	p	D86N	0	.	.	256	258	GAC	542	544	GAC	178;178;178	G;A,T,G;C	174;168,1,1;173	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4208	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2879	144.6	1	SNP	p	R87I	0	.	.	259	261	CGT	545	547	CGT	178;179;179	C,T;G;T	173,1;174;171	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4208	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2879	144.6	1	SNP	p	S87R	1	.	.	259	261	CGT	545	547	CGT	178;179;179	C,T;G;T	173,1;174;171	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4208	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2879	144.6	1	SNP	p	R87W	0	.	.	259	261	CGT	545	547	CGT	178;179;179	C,T;G;T	173,1;174;171	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4208	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2879	144.6	1	SNP	p	S88P	0	.	.	262	264	TCC	548	550	TCC	175;175;174	T;C;C	167;169;168	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2868	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2701	105.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1605	1607	GGC	121;119;120	G;G;C	118;115;117	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	121.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1304	1306	GCC	173;173;176	G;C;C,A	166;168;166,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	121.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1307	1309	ATG	180;179;180	A;T;G	177;174;175	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	121.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1319	1321	ACC	177;178;180	A;C;C	167;174;173	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	121.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1319	1321	ACC	177;178;180	A;C;C	167;174;173	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	121.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1820	1822	ACC	153;153;155	A,C;C;C	141,1;150;150	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	121.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1874	1876	GCG	154;152;153	G;C;G	150;146;144	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	121.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1874	1876	GCG	154;152;153	G;C;G	150;146;144	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	121.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1997	1999	GGT	106;104;103	G;G;T	101;100;100	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	121.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2006	2008	AGC	98;97;97	A;G;C	96;95;95	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3060	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2512	121.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2024	2026	CCG	78;81;82	C,G;C,G;G	67,3;71,1;72	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4718	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3201	146.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1620	1622	CCG	149;149;149	C,A;C;G	139,1;146;139	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1886	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1758	105.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	547	547	C	134	C	125	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	188	90.1	porB1a.l6.c30.ctg.1	1313	14.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1150	1152	AAT	13;13;13	A;A;T	13;13;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	188	90.1	porB1a.l6.c30.ctg.1	1313	14.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1153	1155	AAT	13;13;13	A;A;T	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	188	90.1	porB1a.l6.c30.ctg.1	1313	14.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1177	1179	GCA	9;9;9	G;C;A	9;9;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	188	90.1	porB1a.l6.c30.ctg.1	1313	14.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1200	1202	GTA	5;5;5	G;T;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	188	90.1	porB1a.l6.c30.ctg.1	1313	14.8	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1209	1209	A	5	A	5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	A251V	NONSYN	751	753	GCG	41	43	GTA	20;20;20	G;T,G;A	13;12,1;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	S271T	NONSYN	811	813	TCG	101	103	ACT	37;37;36	A;C;T	35;34;34	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	107	109	GAT	32;32;28	G;A;T	32;30;28	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	D276N	NONSYN	826	828	GAT	116	118	AAC	28;28;28	A;A;C	27;27;28	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	N277H	NONSYN	829	831	AAC	119	121	CAC	29;29;29	C;A;C	29;29;29	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	R307E	NONSYN	919	921	AGA	209	211	GAA	10;10;10	G;A;A	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	221	223	GCA	9;8;8	G;C;A	9;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	E312D	NONSYN	934	936	GAA	224	226	GAC	9;9;9	G;A;C	9;8;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	230	232	ATC	10;9;9	A;T;C	10;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	236	238	TCG	9;9;9	T;C;G	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	242	244	GCC	9;9;11	G;C;C	8;9;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	245	247	AGC	11;11;11	A;G;C	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	248	250	GCC	11;11;11	G;C;C	10;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	272	porB1a	984	271	91.51	porB1a.l6.c30.ctg.2	276	21.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	254	256	GTT	11;11;11	G;T;T	11;11;11	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2596	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1523	168.5	0	.	p	.	0	E209K	NONSYN	625	627	GAA	871	873	AAA	205;206;209	A,G;A;A	201,1;204;208	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2596	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1523	168.5	0	.	p	.	0	A212E	NONSYN	634	636	GCA	880	882	GAA	189;188;186	G;A,C;A	187;184,1;186	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2596	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1523	168.5	1	SNP	p	G120K	1	.	.	358	360	AAG	604	606	AAG	205;207;207	A;A;G	195;201;195	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2596	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1523	168.5	1	SNP	p	N121D	0	.	.	361	363	AAC	607	609	AAC	209;208;205	A;A;C	201;200;195	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2596	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1523	168.5	1	SNP	p	A121N	1	.	.	361	363	AAC	607	609	AAC	209;208;205	A;A;C	201;200;195	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9134	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4992	181.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	966	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1076	88.9	1	SNP	p	V57M	1	.	.	169	171	ATG	568	570	ATG	171;173;173	A;T;G	168;170;167	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
